Bernhard, J., Luo, W., Ribi, K., Colleoni, M., Burstein, H. J., Tondini, C., Pinotti, G., Spazzapan, S., Ruhstaller, T., Puglisi, F., Pavesi, L., Parmar, V., Regan, M. M., Pagani, O., Fleming, G. F., Francis, P. A., Price, K. N., Coates, A. S., Gelber, R. D., Goldhirsch, A., & Walley, B. A. (n.d.). patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Lancet oncology, 16(7), 848–858. http://access.bl.uk/ark:/81055/vdc_100025942483.0x000049